enGene Therapeutics Inc. (ENGN)
Nasdaq • ENGN • CA29286X1015
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 4.2% of free float sold short, 1.6 days to cover, cost to borrow 0.9%. Sign up for live short interest data.
Market Cap
117m USD | # 8192 in US
Volume
805.82k shares | 1.43m USD
Shares Outstanding
67.02m
Free Float Shares
49.29% | 33.03m
